Amedica (AMDA) Misses Q2 EPS by 9c

August 11, 2016 4:42 PM EDT
Get Alerts AMDA Hot Sheet
Trade AMDA Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Amedica (NASDAQ: AMDA) reported Q2 EPS of ($0.40), $0.09 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $4 million versus the consensus estimate of $4.2 million.

For earnings history and earnings-related data on Amedica (AMDA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment